Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
—1,100.571,098.941,103.801,084.24——
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
—605.15605.15606.69602.76——
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
—1,195.191,204.711,221.691,204.71——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
—1,739.911,734.501,734.501,710.67——
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
—638.56640.21645.32638.69——
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
—831.57840.48844.16834.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
—213.36213.36215.79212.77——
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
—3,234.183,171.863,195.363,145.46——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
—935.65937.31941.44933.16——
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
—1,449.261,454.771,462.651,447.95——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
—2,382.452,371.192,380.452,362.86——
HLNCF:OTCMKTS
Haleon PLC
$4.70
-1.68%
(-0.080) 1D
Apr 28, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HLNCF...
Open
$4.72
High
$4.72
Low
$4.70
Mkt. cap
42.09B
Avg. vol.
10.70K
Volume
2.01K
52-wk high
$5.80
52-wk low
$4.25
Beta
-24.47
Shares outstanding
8.89B
No. of employees
25K
News stories
From sources across the web
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022. Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC
CEO-
Employees24.5K
FoundedJul 18, 2022
Headquarters-
SectorPharmaceutical industry
Websitehaleon.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.74B
2.74B
2.78B
2.78B
Cost of goods sold
972.50M
972.50M
970.50M
970.50M
Cost of revenue
972.50M
972.50M
970.50M
970.50M
Research and development expenses
76.00M
76.00M
81.50M
81.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.08B
1.08B
1.08B
1.08B
Operating expense
1.16B
1.16B
1.16B
1.16B
Total operating expenses
2.13B
2.13B
2.13B
2.13B
Operating income
608.50M
608.50M
643.00M
643.00M
Other non operating income
500.00K
500.00K
-10.50M
-10.50M
EBT including unusual items
537.50M
537.50M
538.50M
538.50M
EBT excluding unusual items
544.50M
544.50M
552.00M
552.00M
Income tax expense
131.00M
131.00M
105.00M
105.00M
Effective tax rate
24.37%
24.37%
19.50%
19.50%
Other operating expenses
-
-
-
-
Net income
403.00M
403.00M
430.50M
430.50M
Net profit margin
14.71%
14.71%
15.51%
15.51%
Earnings per share
-
-
-
-
Interest and investment income
23.50M
23.50M
5.00M
5.00M
Interest expense
-88.00M
-88.00M
-85.50M
-85.50M
Net interest expenses
-64.50M
-64.50M
-80.50M
-80.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
667.00M
667.00M
704.50M
704.50M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer